Advances in clinical trial design: Weaving tomorrow's TB treatments

PLoS Med. 2020 Feb 27;17(2):e1003059. doi: 10.1371/journal.pmed.1003059. eCollection 2020 Feb.

Abstract

Christian Lienhardt and co-authors discuss the conclusions of the PLOS Medicine Collection on advances in clinical trial design for development of new tuberculosis treatments.

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / therapeutic use*
  • Clinical Trials as Topic / economics
  • Clinical Trials as Topic / methods*
  • Clinical Trials, Phase II as Topic / economics
  • Clinical Trials, Phase II as Topic / methods
  • Clinical Trials, Phase III as Topic / economics
  • Clinical Trials, Phase III as Topic / methods
  • Drug Development
  • Drug Evaluation, Preclinical
  • Humans
  • Medication Adherence
  • Time Factors
  • Translational Research, Biomedical
  • Tuberculosis / drug therapy*
  • Vulnerable Populations

Substances

  • Antitubercular Agents